Position in OCUL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,222,167
-$628,341 QoQ
Shares Held
124,457
-43.0% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#94
of 257 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,016,183,849 across 217 Biotechnology names. OCUL ranks #146 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in OCUL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,222,167 | 124,457 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,850,508 | 218,478 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $14,008,466 | 1,153,910 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,324,231 | 113,279 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $954,290 | 102,833 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $440,701 | 60,123 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $268,318 | 31,419 | Shares | Defined | 2025-02-14 | |
| 2024-03-31 | $1,457,292 | 160,142 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,743,123 | 390,835 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,836,523 | 584,880 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,385,500 | 656,105 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,795,787 | 1,099,770 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,721,018 | 968,334 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,287,999 | 792,289 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,008,829 | 748,465 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,037,013 | 613,538 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,343,285 | 479,668 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,671,020 | 567,102 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,744,212 | 687,180 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $10,701,420 | 652,128 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $21,729,742 | 1,049,746 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,077,438 | 272,988 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,511,378 | 421,534 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $198,851 | 40,172 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||